For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges are well known, such as loss of muscle ...

Share on Pinterest Recent research has found that despite the benefits, people using GLP-1s may be less likely to exercise. Image Credit: Fiordaliso/Getty Images A recent study found that people ...

Recent research has found that despite the benefits, people using GLP-1s may be less likely to exercise. Image Credit: Fiordaliso/Getty Images A recent study found that people who begin using a GLP-1 ...

A new study led by researchers at the University of Texas at El Paso found that use of weight-loss drugs like Ozempic and other GLP-1s is associated with a lower risk of developing alcohol, opioid, ...

Having gone from diabetes treatment to weight-loss miracle, GLP-1s are already blockbuster drugs. Now a new study in The Lancet shows that GLP-1s help with another common lifestyle disease: ...

A new study from the University of St Andrews suggests weight-loss drugs like Ozempic taken around pregnancy do not raise the risk of major birth defects. Published in the American Journal of ...

A GLP-1 medication helped people with obesity who were undergoing treatment for alcohol-use disorder drink less, according to new research. The study, which was published Friday in The Lancet, ...

A 26-week, randomized, double-blind trial in Copenhagen enrolled adults 18–70 years with AUD, BMI ≥30 kg/m², ≥6 heavy-drinking days, and AUDIT >15, assigning semaglutide vs placebo 1:1. Compared with ...

In 2025, a KFF Tracking Poll found that one in eight Americans was taking an injection of a GLP-1 medication such as semaglutide or tirzepatide for weight loss. Today, that's changing dramatically as ...

Before the rise of GLP-1s, obesity experts didn’t study the internal buzz that compels people to eat. Now that food noise is being switched off, they want to understand it. Credit...Xia Gordon ...